DailyIQ
|
Sector:Consumer DefensiveAll sectors
Last updated 2 minutes ago

KVUE·Kenvue Inc.

$.
-. (-.%)
After Hours
High
$17.76
Open
$17.59
Market Cap
33.96B
52W High
$24.00
Low
$17.56
P. Close
$17.71
P/E
20.94
52W Low
$14.02
Fwd P/E
14.30
Mean Target
$19.50
Technical Score (1D)
64
BUY
News Sentiment
70
BULLISH
Kenvue (KVUE) has received a Zacks Rank #1 (Strong Buy) designation, highlighting positive analyst sentiment and strong income stock potential. This recent upgrade, along with a previous one on May 11th, suggests a potentially favorable outlook for the company. Investors are also monitoring Kenvue's partnership with Greyparrot, an AI waste intelligence firm, aimed at improving packaging recyclability. This collaboration, driven by increasing regulatory pressures, will leverage real-world data to inform packaging design and address operational and cost implications. The focus on packaging recyclability aligns with broader ESG initiatives and could lead to operational efficiencies. In other news, Kenvue and L'Oreal SA (LRLCY) are being compared as value stock candidates, with Kenvue currently holding a stronger Zacks Rank. Separately, the Asia Pacific Dental Federation, supported by Kenvue, is advocating for a prevention-first approach to oral health, emphasizing the link between oral hygiene and overall well-being. This initiative could indirectly benefit Kenvue's oral care product lines. Recent institutional activity shows Cullen Frost Bankers significantly increasing its stake in Kenvue, indicating ongoing investor interest. Looking ahead, traders will watch for further developments on the Greyparrot partnership's impact on sustainability goals and any shifts in analyst sentiment regarding Kenvue's value proposition.
Earnings Summary
Kenvue Inc. is a global consumer health company with a diverse portfolio of well-known brands across its Self Care, Skin Health and Beauty, and Essential Health segments. Operating internationally, Kenvue offers a broad range of consumer health solutions, positioning it within the Consumer Defensive sector's Household & Personal Products industry. The company's recent performance shows a pattern of exceeding analyst expectations for earnings per share. In Q1 2026, Kenvue reported actual EPS of $0.32, surpassing the estimate of $0.30627, and revenue of $3.909 billion, slightly below the estimate of $3.919 billion. This follows a strong Q4 2025 where actual EPS of $0.27 beat the estimate of $0.2256, with actual revenue of $3.780 billion exceeding the estimate of $3.754 billion. Prior to this, Kenvue demonstrated consistent EPS beats in Q3 2025 ($0.28 actual vs $0.26485 estimate), Q2 2025 ($0.29 actual vs $0.2837 estimate), and Q1 2025 ($0.24 actual vs $0.22766 estimate), indicating a positive trend in meeting or surpassing earnings targets. Revenue figures for earlier quarters were not provided with estimates, making a direct comparison difficult. Recent news highlights Kenvue's Q1 2026 results, which included a 4.5% increase in net sales and a 33% rise in adjusted diluted EPS to $0.32, alongside a 47% jump in diluted EPS to $0.25. This strong operational performance, particularly in skin health and beauty, occurred amidst speculation about a potential acquisition by Kimberly-Clark. Investors will be watching for Kenvue's ability to sustain this sales and profitability momentum in the upcoming quarters, especially considering the ongoing macroeconomic variability and the potential impact of the anticipated acquisition closing in the latter half of 2026.

EPS

EstBeatMiss
$0.21$0.24$0.27$0.30$0.33Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.32 - -
Q1'26$0.31$0.32+4.5%
Q4'25$0.23$0.27+19.7%
Q3'25$0.26$0.28+5.7%
Q2'25$0.28$0.29+2.2%
Q1'25$0.23$0.24+5.4%

Revenue

EstBeatMiss
$3.7B$3.8B$3.9B$3.9B$4.0BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$4.0B - -
Q1'26$3.9B$3.9B-0.3%
Q4'25$3.8B$3.8B+0.7%
Q3'25 - $3.8B -
Q2'25 - $3.8B -
Q1'25 - $3.7B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

KVUE Stock Snapshot

KVUE is currently trading at $17.70, giving Kenvue Inc. a market cap of 33.96B and a P/E ratio of 20.9. Today's range spans $17.56–$17.76, with shares opening at $17.59 and moving down $0.01 (0.1%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 70/100.

Over the past year KVUE has traded between $14.02 and $24.00 - the current price is +26.2% off the 52-week low and -26.3% from the high. 21 analysts cover the stock with a Hold consensus and a mean 12-month target of $19.50 (range $18.00–$23.00), implying upside of +10.2%.

A HOLD read (64/100) for KVUE at $17.70 (in the lower half of its 52-week range) with bullish sentiment (70/100) tells the story of a large-cap Consumer Defensive stock between identifiable trends. The current P/E ratio stands at 20.9. The 33.96B market cap keeps institutional interest alive; the 52-week range of $14.02–$24.00 keeps the trade interesting. HOLD signals here aren't an endpoint - they're a setup phase waiting for the right trigger.

Portfolio construction in Consumer Defensive often uses large-cap names like KVUE as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 64/100 (HOLD) at $17.70 (in the lower half of its 52-week range) and bullish sentiment (70/100) frame the position as a catalyst play within the $14.02–$24.00 annual range rather than a directional bet.